{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:51:21Z","timestamp":1793109081271,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009122","name":"Ministry of Higher Education and Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009122","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Rome"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.biochi.2018.04.026","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T22:45:51Z","timestamp":1525387551000},"page":"80-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Plasma oxysterol profiling in children reveals 24-hydroxycholesterol as a potential marker for Autism Spectrum Disorders"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4942-0538","authenticated-orcid":false,"given":"S.","family":"Grayaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zerbinati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Messedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"HadjKacem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Chtourou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ben Touhemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Naifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ayadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ayedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0027-9326","authenticated-orcid":false,"given":"L.","family":"Iuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2018.04.026_bib1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jamapediatrics.2015.2125","article-title":"Link between increased prevalence of autism spectrum disorder syndromes and oxidative stress, DNA methylation, and imprinting: the impact of the environment","volume":"169","author":"Menezo","year":"2015","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.biochi.2018.04.026_bib2","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/14737175.2017.1351301","article-title":"An evaluation of the clinical application of the DSM-5 for the diagnosis of autism spectrum disorder","volume":"17","author":"Burns","year":"2017","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.biochi.2018.04.026_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00401-017-1736-4","article-title":"Autism spectrum disorder: neuropathology and animal models","volume":"134","author":"Varghese","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biochi.2018.04.026_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.brainres.2010.09.101","article-title":"Brain growth across the life span in autism: age-specific changes in anatomical pathology","volume":"1380","author":"Courchesne","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.biochi.2018.04.026_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/mp.2011.165","article-title":"A\u00a0review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.biochi.2018.04.026_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jped.2016.01.012","article-title":"Prenatal, perinatal and postnatal factors associated with autism spectrum disorder","volume":"92","author":"Hadjkacem","year":"2016","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.biochi.2018.04.026_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fnmol.2017.00034","article-title":"Metabolic dysfunction underlying autism spectrum disorder and potential treatment approaches","volume":"10","author":"Cheng","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biochi.2018.04.026_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/pcn.12606","article-title":"Genetics and epigenetics of autism: a Review","volume":"72","author":"Waye","year":"2018","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.biochi.2018.04.026_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jcp.25488","article-title":"Can cholesterol metabolism modulation affect brain function and behavior?","volume":"232","author":"Cartocci","year":"2017","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.biochi.2018.04.026_bib10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s11011-017-0015-3","article-title":"Cholesterol as a modifying agent of the neurovascular unit structure and function under physiological and pathological conditions","volume":"32","author":"Czuba","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biochi.2018.04.026_bib11","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/aur.1777","article-title":"The role of cholesterol metabolism and various steroid abnormalities in autism spectrum disorders: a hypothesis paper","volume":"10","author":"Gillberg","year":"2017","journal-title":"Autism Res."},{"key":"10.1016\/j.biochi.2018.04.026_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.32607\/20758251-2017-9-1-26-37","article-title":"Cholesterol in the pathogenesis of Alzheimer's, Parkinson's diseases and autism: link to synaptic dysfunction","volume":"9","author":"Petrov","year":"2017","journal-title":"Acta Naturae"},{"key":"10.1016\/j.biochi.2018.04.026_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnbeh.2014.00104","article-title":"Lipid rafts: a signaling platform linking cholesterol metabolism to synaptic deficits in autism spectrum disorders","volume":"8","author":"Wang","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.biochi.2018.04.026_bib14","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s11064-011-0697-6","article-title":"Cholesterol, GM1, and autism","volume":"37","author":"Schengrund","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biochi.2018.04.026_bib15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01725.x","article-title":"Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain","volume":"260","author":"Bjorkhem","year":"2006","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.biochi.2018.04.026_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.chemphyslip.2011.06.006","article-title":"Pathways of cholesterol oxidation via non-enzymatic mechanisms","volume":"164","author":"Iuliano","year":"2011","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.biochi.2018.04.026_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.2000.80.1.361","article-title":"Oxysterols: modulators of cholesterol metabolism and other processes","volume":"80","author":"Schroepfer","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biochi.2018.04.026_bib18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.bbrc.2014.02.010","article-title":"Diverse functions of 24(S)-hydroxycholesterol in the brain","volume":"446","author":"Noguchi","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2018.04.026_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.steroids.2015.01.026","article-title":"Cholesterol metabolites exported from human brain","volume":"99","author":"Iuliano","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.biochi.2018.04.026_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.plipres.2016.09.002","article-title":"Oxysterols: from cholesterol metabolites to key mediators","volume":"64","author":"Mutemberezi","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.biochi.2018.04.026_bib21","doi-asserted-by":"crossref","first-page":"15521","DOI":"10.1074\/jbc.R700049200","article-title":"Cholesterol, reactive oxygen species, and the formation of biologically active mediators","volume":"283","author":"Murphy","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2018.04.026_bib22","first-page":"1","article-title":"An update on oxysterol biochemistry: new discoveries in lipidomics","author":"Griffiths","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2018.04.026_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mam.2016.02.004","article-title":"Oxysterols and mechanisms of survival signaling","volume":"49","author":"Vurusaner","year":"2016","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.biochi.2018.04.026_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.redox.2017.07.014","article-title":"Endothelial cells, endoplasmic reticulum stress and oxysterols","volume":"13","author":"Luchetti","year":"2017","journal-title":"Redox Biol"},{"key":"10.1016\/j.biochi.2018.04.026_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.mam.2009.02.006","article-title":"Cytotoxic effects of oxysterols associated with human diseases: induction of cell death (apoptosis and\/or oncosis), oxidative and inflammatory activities, and phospholipidosis","volume":"30","author":"Vejux","year":"2009","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.biochi.2018.04.026_bib26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.chemphyslip.2011.04.002","article-title":"Oxysterols as biomarkers in neurodegenerative diseases","volume":"164","author":"Leoni","year":"2011","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.biochi.2018.04.026_bib27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fnmol.2018.00012","article-title":"Biomarkers of amyotrophic lateral sclerosis: current status and interest of oxysterols and phytosterols","volume":"11","author":"Vejux","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biochi.2018.04.026_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.freeradbiomed.2016.10.008","article-title":"Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson's disease","volume":"101","author":"Doria","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biochi.2018.04.026_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jsbmb.2016.03.018","article-title":"Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients","volume":"169","author":"Griffiths","year":"2017","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.biochi.2018.04.026_bib30","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1515\/cclm-2015-0669","article-title":"High level of oxysterols in neonatal cholestasis: a pitfall in analysis of biochemical markers for Niemann-Pick type C disease","volume":"54","author":"Polo","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.biochi.2018.04.026_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.32607\/20758251-2016-8-1-58-73","article-title":"Brain cholesterol metabolism and its defects: linkage to neurodegenerative diseases and synaptic dysfunction","volume":"8","author":"Petrov","year":"2016","journal-title":"Acta Naturae"},{"key":"10.1016\/j.biochi.2018.04.026_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biochi.2018.04.026_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.beem.2013.10.010","article-title":"Targeting LDL: is lower better and is it safe?","volume":"28","author":"Stein","year":"2014","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.biochi.2018.04.026_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.steroids.2015.03.019","article-title":"Effect of obesity and metabolic syndrome on plasma oxysterols and fatty acids in human","volume":"99","author":"Tremblay-Franco","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.biochi.2018.04.026_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-150734","article-title":"Cholesterol, 24-hydroxycholesterol, and 27-hydroxycholesterol as surrogate biomarkers in cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease: a meta-analysis","volume":"51","author":"Wang","year":"2016","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biochi.2018.04.026_bib36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3233\/JAD-2012-121585","article-title":"Brain cholesterol metabolism, oxysterols, and dementia","volume":"33","author":"Hughes","year":"2013","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biochi.2018.04.026_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.biochi.2012.09.025","article-title":"24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases","volume":"95","author":"Leoni","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.biochi.2018.04.026_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nbd.2013.03.013","article-title":"Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression","volume":"55","author":"Leoni","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biochi.2018.04.026_bib39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neulet.2013.09.003","article-title":"Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease","volume":"555","author":"Bjorkhem","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biochi.2018.04.026_bib40","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/1352458516666187","article-title":"Interdependence of oxysterols with cholesterol profiles in multiple sclerosis","volume":"23","author":"Mukhopadhyay","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.biochi.2018.04.026_bib41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.redox.2016.09.001","article-title":"Changes in brain oxysterols at different stages of Alzheimer's disease: their involvement in neuroinflammation","volume":"10","author":"Testa","year":"2016","journal-title":"Redox Biol"},{"key":"10.1016\/j.biochi.2018.04.026_bib42","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ajmg.b.30368","article-title":"Abnormalities of cholesterol metabolism in autism spectrum disorders","volume":"141B","author":"Tierney","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.biochi.2018.04.026_bib43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.chemphyslip.2017.05.007","article-title":"Cholesterol metabolism and glaucoma: modulation of Muller cell membrane organization by 24S-hydroxycholesterol","volume":"207","author":"Gambert","year":"2017","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.biochi.2018.04.026_bib44","article-title":"24S-hydroxycholesterol and 25-hydroxycholesterol differentially impact hippocampal neuronal survival following oxygen-glucose deprivation","volume":"12","author":"Sun","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2018.04.026_bib45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12640-012-9354-3","article-title":"Excitotoxicity in the pathogenesis of autism","volume":"23","author":"Essa","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.biochi.2018.04.026_bib46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/0269881118754680","article-title":"Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: therapeutic implications","volume":"32","author":"Olloquequi","year":"2018","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.biochi.2018.04.026_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuropharm.2017.01.030","article-title":"24S-Hydroxycholesterol enhances synaptic vesicle cycling in the mouse neuromuscular junction: implication of glutamate NMDA receptors and nitric oxide","volume":"117","author":"Kasimov","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biochi.2018.04.026_bib48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.dib.2016.02.025","article-title":"Data of multiple regressions analysis between selected biomarkers related to glutamate excitotoxicity and oxidative stress in Saudi autistic patients","volume":"7","author":"El-Ansary","year":"2016","journal-title":"Data Brief"},{"key":"10.1016\/j.biochi.2018.04.026_bib49","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.09.011","article-title":"Disrupted ionic homeostasis in ischemic stroke and new therapeutic targets","volume":"26","author":"Hu","year":"2017","journal-title":"J.\u00a0Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.biochi.2018.04.026_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2017.03.005","article-title":"N-methyl-d-aspartate receptor-mediated calcium overload and endoplasmic reticulum stress are involved in interleukin-1beta-induced neuronal apoptosis in rat hippocampus","volume":"307","author":"Dong","year":"2017","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.biochi.2018.04.026_bib51","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.chemphyslip.2017.03.006","article-title":"Evidence of K(+) homeostasis disruption in cellular dysfunction triggered by 7-ketocholesterol, 24S-hydroxycholesterol, and tetracosanoic acid (C24:0) in 158N murine oligodendrocytes","volume":"207","author":"Bezine","year":"2017","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.biochi.2018.04.026_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.biochi.2018.02.008","article-title":"Modulation of Kv3.1b potassium channel level and intracellular potassium concentration in 158N murine oligodendrocytes and BV-2 murine microglial cells treated with 7-ketocholesterol, 24S-hydroxycholesterol or tetracosanoic acid (C24:0)","author":"Bezine","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.biochi.2018.04.026_bib53","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2012.07893.x","article-title":"Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease","volume":"123","author":"Popp","year":"2012","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.biochi.2018.04.026_bib54","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbrc.2007.05.033","article-title":"Regulation of alpha- and beta-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the alpha-secretase pathway","volume":"359","author":"Famer","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2018.04.026_bib55","doi-asserted-by":"crossref","first-page":"26052","DOI":"10.1038\/srep26052","article-title":"Finding novel distinctions between the sAPPalpha-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue","volume":"6","author":"Ray","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biochi.2018.04.026_bib56","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mp.2016.134","article-title":"Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism","volume":"21","author":"Westmark","year":"2016","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.biochi.2018.04.026_bib57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fncel.2013.00094","article-title":"Autism as early neurodevelopmental disorder: evidence for an sAPPalpha-mediated anabolic pathway","volume":"7","author":"Lahiri","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.biochi.2018.04.026_bib58","doi-asserted-by":"crossref","first-page":"16152","DOI":"10.1038\/srep16152","article-title":"Age-associated changes in rich-club organisation in autistic and neurotypical human brains","volume":"5","author":"Watanabe","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biochi.2018.04.026_bib59","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0022-2275(20)32393-2","article-title":"Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface","volume":"41","author":"Bretillon","year":"2000","journal-title":"J.\u00a0Lipid Res."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908418301226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908418301226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:10:41Z","timestamp":1759540241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908418301226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":59,"alternative-id":["S0300908418301226"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2018.04.026","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma oxysterol profiling in children reveals 24-hydroxycholesterol as a potential marker for Autism Spectrum Disorders","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2018.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights reserved.","name":"copyright","label":"Copyright"}]}}